Shanghai-Hong Kong Zhongke
Biopharmaceutical preclinical research and development service company
Company News
2022-03-11
“Pull Together” - AnLing Shenzhen Donates COVID-19 Supplies to Hong KongOn March 9, AnLing Biomed (Shenzhen) Co., Ltd., a wholly-owned subsidiary of ZSHK Laboratories Limited, donated RMB100,000 worth of COVID-19 medical supplies to meet the urgent needs of the Hong Kong people in the pandemic. The supplies were...
Read more +
2021-10-08
ZSHK was invited to participate in the 6th China Pharmaceutical Innovation and Investment Conference, and CEO Dr. Li Ming served as the host of theZSHK was invited to participate in the 6th China Pharmaceutical Innovation and Investment Conference, CEO Dr. Li Ming was invited by the conference organizing committee to serveInnovative drug basic research and achievement transformation ro...
Read more +
2021-07-26
Pre-clinical CRO ZSHK obtained 100 million yuan in Series A financing, led by Qiming Venture PartnersZSHK Laboratories Limited (hereinafter referred to as ZSHK) recently announced the completion of 100 million yuan in Series A financing. This round of financing was led by Qiming Venture Partners and followed by Ascendum Capital. This round ...
Read more +
